To determine whether necroptosis was inactivated in AD mice with NAD+ augmentation, we found that NMN indeed inhibited necroptosis, as evidenced by an apparent reduction in RIPK1, RIPK3, and MLKL expressions by immunoblotting analysis (Supplementary Fig. 3k, l). This evidence concerns the gene MLKL and Alzheimer disease.